Showing results (61-70 of 121) with videos related to
Sort By:
Pageof 13
British Journal of Haematology|February 6, 2016
The outcome of Chronic lymphocytic leukaemia patients with 97% IGHV gene identity to germline is distinct from cases with <97% identity and similar to those with 98% identityZadie Davis, Francesco Forconi, Anton Parker, et al.British Journal of Haematology|September 29, 2012
Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphomaMonica Else, Ana Marín-Niebla, Fátima de la Cruz, et al.Blood|July 2, 2002
ATM mutations are rare in familial chronic lymphocytic leukemiaMartin R Yuille, Alison Condie, Chantelle D Hudson, et al.Cancer|October 26, 2005
Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 yearsMonica Else, Rosa Ruchlemer, Nnenna Osuji, et al.Leukemia & Lymphoma|March 26, 2002
Incidence of MLL rearrangement in acute myeloid leukemia, and a CALM-AF10 fusion in M4 type acute myeloblastic leukemiaSaid M H Abdou, Dalal M Jadayel, Toon Min, et al.Blood|March 1, 2003
A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal diseaseJenny Orchard, Richard Garand, Zadie Davis, et al.Leukemia & Lymphoma|January 7, 2016
Evaluation of serum markers in the LRF CLL4 trial: β2-microglobulin but not serum free light chains, is an independent marker of overall survivalGuy Pratt, Peter Thomas, Nicola Marden, et al.American Journal of Clinical Pathology|November 12, 2003
Diagnostic significance of CD20 and FMC7 expression in B-cell disordersJulio Delgado, Estella Matutes, Alison M Morilla, et al.Haematologica|March 17, 2004
The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytesIlaria Del Giudice, Estella Matutes, Ricardo Morilla, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Mutational status of the TP53 gene as a predictor of response and survival in patients with chronic lymphocytic leukemia: results from the LRF CLL4 trialDavid Gonzalez, Pilar Martinez, Rachel Wade, et al.Pageof 13